BVS compared with TELA: revenue, margins and what each company keeps, and the suppliers and customers both name

BVSBioventus Inc.

Mkt capRevenueRevenue

TELATELA Bio, Inc.

Mkt capRevenueRevenue

Compare

BVSBioventus Inc.

TELATELA Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BVS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±19.9%▲+13.71%×0.69

May 6 '26±17.1%▲+2.25%×0.13

Q1 FY26±17.5%▲+7.44%×0.42

Nov 4 '25±18.0%▲+15.09%×0.84

TELA1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−15.05%—

= impliedBVS realized, solidTELA realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

BVSBioventus Inc.

13.35▼−10.25%· post 13.28

Mkt cap$1.1BRevenue$153MQ2 FY26Revenue$568MFY25

TELATELA Bio, Inc.

0.86▼−7.07%· post 0.81

ClosedOct 30 '26

Mkt cap$36.4MRevenue$19MQ2 FY26Revenue$80MFY25

Compare

ClosedOct 30 '26

BVSBioventus Inc.

TELATELA Bio, Inc.

13.35▼−10.25%post 13.28

Price

0.86▼−7.07%post 0.81

$1.1B

Mkt cap

$36.4M

Q2 FY26$153M

Revenue

$19MQ2 FY26

FY25$568M

Revenue

$80MFY25

BVS13.35▼−10.25%vsTELA0.86▼−7.07%ClosedOct 30 '26